The clinical application of contrast-enhanced ultrasound in ovarian tumors

LI Zai-hong; JING Xiang-xiang

Journal of China Clinic Medical Imaging ›› 2016, Vol. 27 ›› Issue (1) : 62-65.

Author information +

History +

Abstract

Ovarian cancer is one of the most common gynecological tumor which can be classified into different histological types. In recent years the incidence rate of ovarian cancer increased year by year. To characterize ovarian masses enables patients with malignancy to be appropriately triaged for treatment, which has been shown to further optimized care and improved survival. There are many kinds of imaging methods applied in the clinical diagnosis of ovarian cancer, such as transabdominal or transvaginal two-dimensional ultrasound, three-dimensional ultrasound, color and power Doppler ultrasound, computed tomography, magnetic resonance imaging and contrast-enhanced ultrasound. Contrast-enhanced ultrasound is a new technology which can detect the neovascularization in and around the ovarian cancer sensitively, and the time-intensity curve can be drawn by analysis software to help distinguish benign from malignant tumors. Contrast-enhanced ultrasound is a reliable and convenient imaging method and is now more and more widely applied in clinical diagnosis.

Key words

Ovarian neoplasms / Ultrasonography, Doppler, color

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

LI Zai-hong， JING Xiang-xiang. The clinical application of contrast-enhanced ultrasound in ovarian tumors[J]. Journal of China Clinic Medical Imaging. 2016, 27(1): 62-65

References

[1]Demirci E, Daloglu FT, Calik M, et al. Changing Trends in the Incidence of Ovarian Neoplasia and Its Relationship with the Risk Factors: A Report of 311 Cases from North-Eastern Anatolia Region[J]. Eurasian J Med, 2015, 47(1): 48-55.
[2]Brain KE, Smits S, Simon AE, et al. Ovarian cancer symptom awareness and anticipated delayed presentation in a population sample[J]. BMC Cancer, 2014, 14(171): 1-10.
[3]Singh SD, Ryerson B, Wu M, et al. Ovarian and Uterine Cancer Incidence and Mortality in American Indian and Alaska Native Women, United States, 1999-2009[J]. Am J Public Health, 2014, 104(3): 423-431.
[4]Lee JY, Kim EY, Jung KW, et al. Trends in gynecologic cancer mortality in East Asian regions[J]. J Gynecol Oncol, 2014, 25(3): 174.
[5]雷亚平. 卵巢肿瘤412例患者的临床病理特点分析[J]. 山西医科大学学报，2013，44（3）：230-233.
[6]吴俊改. 肿瘤标记物、超声检查在卵巢肿瘤诊断中的应用[J]. 现代中西医结合杂志，2013，22（8）：877-879.
[7]高淳，文智. 影像学联合肿瘤标志物对卵巢癌诊断的研究进展[J]. 医学综述，2014，20（5）：894-896.
[8]Sayasneh A, Ekechi C, Ferrara L, et al. The characteristic ultrasound features of specific types of ovarian pathology(review)[J]. Int J Oncol, 2015, 46(2): 445-458.
[9]胡鸣，洪莉，陈璐，等. 超声造影结合参数图像处理在诊断卵巢恶性肿瘤中的应用价值[J]. 临床超声医学杂志，2014，16（12）：800-802.
[10]王勇，周纯武，郝玉芝. 超声造影技术及其在卵巢肿瘤诊断中的应用[J]. 放射学实践，2006，21（11）：1182-1185.
[11]李丽，吴青青，谢玉娴. 应用超声鉴别卵巢肿瘤良恶性的研究进展[J]. 临床超声医学杂志，2006，8（6）：363-365.
[12]王军燕，刘爱军，崔秋丽，等. 卵巢肿瘤超声造影与微血管密度的相关性研究[J]. 中华医学超声杂志：电子版，2011，8（1）：103-110.
[13]Kurjak A, Kupesic S, Anic T, et al. Three-Dimensional Ultrasound and Power Doppler Improve the Diagnosis of Ovarian Lesions[J]. Gynecol Oncol, 2000, 76(1): 28-32.
[14]Wang J, Lv FQ, Fei X, et al. Study on the Characteristics of Contrast-Enhanced Ultrasound and Its Utility in Assessing the Microvessel Density in Ovarian Tumors or Tumor-Like Lesions[J]. Int J Biol Sci, 2011, 6(7): 600-606.
[15]王军燕，崔秋丽，刘爱军，等. 经阴道增强超声造影鉴别诊断附件区良、恶性包块的临床价值[J]. 中国医学影像学杂志，2009，17（6）：412-415.
[16]许幼峰，郭华，舒静，等. 超声造影在卵巢肿瘤诊断中的初步应用[J]. 中国超声医学杂志，2007，23（7）：534-537.
[17]张煜，周静，李明星，等. 超声造影在卵巢肿瘤定性诊断中的临床价值[J]. 临床超声医学杂志，2013，15（6）：403-405.
[18]Gramiak R, Shah PM. Echocardiography of the aortic root[J]. Invest Radiol, 1968, 3(5): 356-366.
[19]Fritzsch T, Schartl M, Siegert J. Preclinical and clinical results with an ultrasonic contrast agent[J]. Invest Radiol, 1988, 23(Suppl 1): S302-S305.
[20]Suren A, Osmers R, Kulenkampff D, et al. Visualization of blood flow in small ovarian tumor vessels by transvaginal color Doppler sonography after echo enhancement with injection of Levovist[J]. Gynecol Obstet Invest, 1994, 38(3): 210-212.
[21]Chung YE, Kim KW. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging[J]. Ultrasonography, 2015, 34(1): 3-18.
[22]Testa AC, Ferrandina G, Fruscella E, et al. The use of contrasted transvaginal sonography in the diagnosis of gynecologic diseases: a preliminary study[J]. J Ultrasound Med, 2005, 24(9): 1267-1278.
[23]冯玉玲，向红. 超声造影在诊断卵巢肿瘤中的应用[J]. 中国介入影像与治疗学，2011，8（1）：62-65.
[24]胡超. 超声谐波成像研究[D]. 南京：南京大学，2013：1-47.
[25]Fleischer AC, Lyshchik A, Jr Jones HW, et al. Contrast-Enhanced Transvaginal Sonography of Benign Versus Malignant Ovarian Masses[J]. J Ultrasound Med, 2008, 27(7): 1011-1018.
[26]刘百灵，周琦，姜珏，等. 超声造影在卵巢肿瘤诊断中的应用价值[J]. 中国超声医学杂志，2008，25（9）：831-833.
[27]顾蔚蓉，丰有吉，张珏华. Levovist在超声鉴别诊断卵巢良恶性肿瘤中的应用研究[J]. 中华超声影像学杂志，2003，12（9）：534-537.
[28]Staub D, Partovi S, Imfeld S. Novel applications of contrast-enhanced ultrasound imaging in vascular medicine[J]. Vasa, 2013, 42(1): 17-31.
[29]Fleischer AC, Lyshchik A, Andreotti RF, et al. Advances in Sonographic Detection of Ovarian Cancer: Depiction of Tumor Neovascularity With Microbubbles[J]. AJR, 2010, 194(2): 343-348.
[30]张晟，李春香，忻晓洁. 超声造影对卵巢良恶性肿瘤鉴别诊断的研究进展[J]. 中国肿瘤临床，2013，40（7）：420-422.
[31]王军燕，崔秋丽，汪龙霞，等. 超声造影在卵巢良恶性肿块鉴别诊断中的应用[J]. 中华医学超声杂志：电子版，2010，7（7）：1152-1161.
[32]张金娥，陈文卫，张玉国，等. 超声造影增强模式对卵巢肿瘤的诊断价值[J]. 中国临床医学影像杂志，2009，20（8）：620-622.
[33]陈茹，黄邹琴，林剑英，等. 超声造影在卵巢肿瘤鉴别诊断中的应用研究[J]. 实用医学杂志，2010，26（23）：4360-4362.